Longhitano, E. et al. The hypertensive disorders of pregnancy: a focus on definitions for clinical nephrologists. J. Clin. Med. 11, 3420 (2022).
Google Scholar
Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341–354 (2021).
Google Scholar
Magee, L. A., Nicolaides, K. H. & von Dadelszen, P. Preeclampsia. N. Engl. J. Med. 386, 1817–1832 (2022).
Google Scholar
Garovic, V. D. et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J. Am. Coll. Cardiol. 75, 2323–2334 (2020).
Google Scholar
Vikse, B. E., Irgens, L. M., Leivestad, T., Skjaerven, R. & Iversen, B. M. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800–809 (2008).
Google Scholar
Barrett, P. M. et al. Adverse pregnancy outcomes and long-term maternal kidney disease: a systematic review and meta-analysis. JAMA Netw. Open 3, e1920964 (2020).
Google Scholar
Covella, B. et al. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. Kidney Int. 96, 711–727 (2019).
Google Scholar
Garovic, V. D. & Piccoli, G. B. A kidney-centric view of pre-eclampsia through the kidney-placental bidirectional lens. Kidney Int. 104, 213–217 (2023).
Google Scholar
Kattah, A. G. et al. Preeclampsia and ESRD: the role of shared risk factors. Am. J. Kidney Dis. 69, 498–505 (2017).
Google Scholar
Cabiddu, G. et al. Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study. Nephrol. Dial. Transpl. 37, 1488–1498 (2022).
Google Scholar
Ibarra-Hernandez, M. et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from Mexico. J. Nephrol. 30, 773–780 (2017).
Google Scholar
van Oostwaard, M. F. et al. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am. J. Obstet. Gynecol. 212, 624.e1–624.e17 (2015).
Google Scholar
Dimitriadis, E. et al. Pre-eclampsia. Nat. Rev. Dis. Primers 9, 8 (2023).
Google Scholar
Piccoli, G. B. et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J. Nephrol. 30, 307–317 (2017).
Google Scholar
Piccoli, G. B. et al. Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int. 93, 278–283 (2018).
Google Scholar
Innes, K. E., Marshall, J. A., Byers, T. E. & Calonge, N. A woman’s own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease. Epidemiology 10, 153–160 (1999).
Google Scholar
Luyckx, V. A. et al. A developmental approach to the prevention of hypertension and kidney disease: a report from the low birth weight and nephron number working group. Lancet 390, 424–428 (2017).
Google Scholar
Homer, C. S., Brown, M. A., Mangos, G. & Davis, G. K. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J. Hypertens. 26, 295–302 (2008).
Google Scholar
[No authors listed] Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet. Gynecol. 135, e237–e260 (2020).
Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management recommendations for international practice. Pregnancy Hypertens. 27, 148–169 (2022).
Google Scholar
[No authors listed] ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet. Gynecol. 133, 1 (2019).
Society of Obstetric Medicine of Australia and New Zealand. Hypertension in Pregnancy Guideline 2023 (SOMANZ, 2024).
Metoki, H. et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens. Res. 45, 1298–1309 (2022).
Google Scholar
Verlohren, S. et al. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 27, 42–50 (2022).
Google Scholar
Rolfo, A. et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 83, 177–181 (2013).
Google Scholar
Cabiddu, G. et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 29, 277–303 (2016).
Google Scholar
Wiles, K. et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 20, 401 (2019).
Google Scholar
Modzelewski, J. et al. Atypical preeclampsia before 20 weeks of gestation — a systematic review. Int. J. Mol. Sci. 24, 3752 (2023).
Google Scholar
Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407–417 (2015).
Google Scholar
Tita, A. T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781–1792 (2022).
Google Scholar
Brewer, J. et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am. J. Obstet. Gynecol. 208, 468.e1–468.e6 (2013).
Google Scholar
Hinchey, J. et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med. 334, 494–500 (1996).
Google Scholar
Garovic, V. D. et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension 79, e21–e41 (2022).
Google Scholar
Santos, J., Schenone, M. H. & Garovic, V. D. Early identification of individuals at risk for hypertensive disorders of pregnancy. JAMA Netw. Open 6, e2334858 (2023).
Google Scholar
Ananth, C. V., Keyes, K. M. & Wapner, R. J. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 347, f6564 (2013).
Google Scholar
Levine, R. J. et al. Trial of calcium to prevent preeclampsia. N. Engl. J. Med. 337, 69–76 (1997).
Google Scholar
Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health 2, e323–e333 (2014).
Google Scholar
Wang, W. et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth 21, 364 (2021).
Google Scholar
Bello, A. K. et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob. Health 12, e382–e395 (2024).
Google Scholar
Lopez, D. S., Hernandez Vargas, J. A., Urina-Jassir, M., Urina-Triana, M. & Franco, O. H. Reducing the gap of chronic kidney disease in low- and middle-income countries: what is missing? Lancet Reg. Health Am. 28, 100625 (2023).
Google Scholar
Stanifer, J. W., Muiru, A., Jafar, T. H. & Patel, U. D. Chronic kidney disease in low- and middle-income countries. Nephrol. Dial. Transpl. 31, 868–874 (2016).
Google Scholar
Torreggiani, M. et al. Unmet needs for CKD care: from the general population to the CKD clinics — how many patients are we missing? Clin. Kidney J. 14, 2246–2254 (2021).
Google Scholar
Williams, D. & Davison, J. Chronic kidney disease in pregnancy. BMJ 336, 211–215 (2008).
Google Scholar
Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341–1347 (2023).
Google Scholar
United Nations Department of Economic and Social Affairs. World Population Prospects 2022: Summary of Results (UNDESA, 2022).
World Health Organization. Trends in Maternal Mortality 2000 to 2020: Estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division (WHO, 2023).
Wheeler, S. M., Myers, S. O., Swamy, G. K. & Myers, E. R. Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019. JAMA Netw. Open 5, e2142343 (2022).
Google Scholar
Hannan, M. et al. Risk factors for CKD progression: overview of findings from the CRIC study. Clin. J. Am. Soc. Nephrol. 16, 648–659 (2021).
Google Scholar
Dilmaghani, D., Nath, K. A. & Garovic, V. D. Increasing maternal mortality in the United States: looking beneath and beyond the numbers. Mayo Clin. Proc. 99, 873–877 (2024).
Google Scholar
Daly, A. L. et al. Risk factors associated with hypertensive disorders of pregnancy within an urban indigenous population in south western Sydney. Intern. Med. J. 48, 269–275 (2018).
Google Scholar
Austin, C. The impact of social determinants of health of Australian indigenous women on access and engagement in maternal child health services. J. Adv. Nurs. 79, 1815–1829 (2023).
Google Scholar
Kendall, S., Lighton, S., Sherwood, J., Baldry, E. & Sullivan, E. A. Incarcerated aboriginal women’s experiences of accessing healthcare and the limitations of the ‘equal treatment’ principle. Int. J. Equity Health 19, 48 (2020).
Google Scholar
Hoy, W. E., Hughson, M. D., Singh, G. R., Douglas-Denton, R. & Bertram, J. F. Reduced nephron number and glomerulomegaly in Australian aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 70, 104–110 (2006).
Google Scholar
Hoy, W. E., Mott, S. A. & Mc Donald, S. P. An expanded nationwide view of chronic kidney disease in aboriginal Australians. Nephrology 21, 916–922 (2016).
Google Scholar
Sorensen, C. & Garcia-Trabanino, R. A new era of climate medicine — addressing heat-triggered renal disease. N. Engl. J. Med. 381, 693–696 (2019).
Google Scholar
Gebremedhin, A. T., Nyadanu, S. D., Hanigan, I. C. & Pereira, G. Maternal exposure to bioclimatic stress and hypertensive disorders of pregnancy in Western Australia: identifying potential critical windows of susceptibility. Env. Sci. Pollut. Res. Int. 31, 52279–52292 (2024).
Google Scholar
Rao, I. R. et al. Chronic kidney disease of unknown aetiology: a comprehensive review of a global public health problem. Trop. Med. Int. Health 28, 588–600 (2023).
Google Scholar
Khan, A. E. et al. Salinity in drinking water and the risk of (pre)eclampsia and gestational hypertension in coastal Bangladesh: a case-control study. PLoS ONE 9, e108715 (2014).
Google Scholar
Mondal, R., Banik, P. C., Faruque, M., Mashreky, S. R. & Ali, L. Association of exposure to salinity in groundwater with chronic kidney disease among diabetic population in Bangladesh. PLoS ONE 18, e0284126 (2023).
Google Scholar
Scheelbeek, P. F., Khan, A. E., Mojumder, S., Elliott, P. & Vineis, P. Drinking water sodium and elevated blood pressure of healthy pregnant women in salinity-affected coastal areas. Hypertension 68, 464–470 (2016).
Google Scholar
Demissie, M., Molla, G., Tayachew, A. & Getachew, F. Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study. Pregnancy Hypertens. 27, 36–41 (2022).
Google Scholar
Beyuo, T. K. et al. Impact of antenatal care on severe maternal and neonatal outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana. Pregnancy Hypertens. 33, 46–51 (2023).
Google Scholar
Nava, J. et al. Successful pregnancy in a CKD patient on a low-protein, supplemented diet: an opportunity to reflect on CKD and pregnancy in Mexico, an emerging country. J. Nephrol. 30, 877–882 (2017).
Google Scholar
Orozco-Guillien, A. O. et al. Quality or quantity of proteins in the diet for CKD patients: does “Junk Food” make a difference? lessons from a high-risk pregnancy. Kidney Blood Press. Res. 46, 1–10 (2021).
Google Scholar
Tyrmi, J. S. et al. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol. 8, 674–683 (2023).
Google Scholar
Reidy, K. J. et al. Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am. J. Hum. Genet. 103, 367–376 (2018).
Google Scholar
Dizon-Townson, D. et al. Impact of smoking during pregnancy on functional coagulation testing. Am. J. Perinatol. 29, 225–230 (2012).
Google Scholar
Loisel, D. A. et al. The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. Mol. Hum. Reprod. 19, 144–152 (2013).
Google Scholar
Conklin, M. B. et al. Understanding health disparities in preeclampsia: a literature review. Am. J. Perinatol. 41, e1291–e1300 (2024).
Google Scholar
Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672–683 (2004).
Google Scholar
Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649–658 (2003).
Google Scholar
Thadhani, R. et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid. 1, EVIDoa2200161 (2022).
Google Scholar
US Food and Drug Administration. FDA roundup: May 19, 2023. FDA (2023).
Dupont, V. et al. Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway. J. Clin. Invest. 132, e158346 (2022).
Google Scholar
Broekhuizen, M., Danser, A. H. J., Reiss, I. K. M. & Merkus, D. The function of the kynurenine pathway in the placenta: a novel pharmacotherapeutic target? Int. J. Environ. Res. Public Health 18, 11545 (2021).
Google Scholar
Yagel, S. et al. Expert review: preeclampsia type I and type II. Am. J. Obstet. Gynecol. MFM 5, 101203 (2023).
Google Scholar
Kidney Disease: Improving Global Outcomes Working Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117–S314 (2024).
Google Scholar
Garovic, V. D. et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 196, 320.e1–320.e7 (2007).
Google Scholar
Jim, B. et al. Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. J. Pregnancy 2012, 984630 (2012).
Google Scholar
Jim, B. et al. A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study. PLoS ONE 9, e101445 (2014).
Google Scholar
Nakamura, T. et al. Urinary podocytes for the assessment of disease activity in lupus nephritis. Am. J. Med. Sci. 320, 112–116 (2000).
Google Scholar
Fisher, K. A., Luger, A., Spargo, B. H. & Lindheimer, M. D. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine 60, 267–276 (1981).
Google Scholar
Gilani, S. I. et al. Urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia. J. Am. Soc. Nephrol. 28, 3363–3372 (2017).
Google Scholar
Weissgerber, T. L., Milic, N. M., Milin-Lazovic, J. S. & Garovic, V. D. Impaired flow-mediated dilation before, during, and after preeclampsia: a systematic review and meta-analysis. Hypertension 67, 415–423 (2016).
Google Scholar
Vikse, B. E., Hallan, S., Bostad, L., Leivestad, T. & Iversen, B. M. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol. Dial. Transpl. 25, 3289–3296 (2010).
Google Scholar
Oliverio, A. L. et al. Renal complications in pregnancy preceding glomerulonephropathy diagnosis. Kidney Int. Rep. 4, 159–162 (2019).
Google Scholar
Cabiddu, G. et al. History of preeclampsia in patients undergoing a kidney biopsy: a biphasic, multiple-hit pathogenic hypothesis. Kidney Int. Rep. 7, 547–557 (2022).
Google Scholar
Conti-Ramsden, F. I. et al. Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes. Hypertension 74, 1144–1151 (2019).
Google Scholar
Gaber, L. W., Spargo, B. H. & Lindheimer, M. D. Renal pathology in pre-eclampsia. Baillieres Clin. Obstet. Gynaecol. 8, 443–468 (1994).
Google Scholar
Kincaid-Smith, P. The renal lesion of preeclampsia revisited. Am. J. Kidney Dis. 17, 144–148 (1991).
Google Scholar
Stillman, I. E. & Karumanchi, S. A. The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 18, 2281–2284 (2007).
Google Scholar
Meibody, F. et al. Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers. Nephrol. Dial. Transpl. 35, 1538–1546 (2020).
Google Scholar
Villie, P. et al. Why kidneys fail post-partum: a tubulocentric viewpoint. J. Nephrol. 31, 645–651 (2018).
Google Scholar
Rodriguez-Benitez, P. et al. Maternal-perinatal variables in patients with severe preeclampsia who develop acute kidney injury. J. Clin. Med. 10, 5629 (2021).
Google Scholar
Sahay, M., Dogra, L., Ismal, K. & Vali, S. Pregnancy-related acute kidney injury in public hospital in South India: changing trends. J. Assoc. Physicians India 70, 11–12 (2022).
Google Scholar
Trakarnvanich, T., Ngamvichchukorn, T. & Susantitaphong, P. Incidence of acute kidney injury during pregnancy and its prognostic value for adverse clinical outcomes: a systematic review and meta-analysis. Medicine 101, e29563 (2022).
Google Scholar
Shalaby, A. S. & Shemies, R. S. Pregnancy-related acute kidney injury in the African continent: where do we stand? A systematic review. J. Nephrol. 35, 2175–2189 (2022).
Google Scholar
Karimi, Z., Malekmakan, L. & Farshadi, M. The prevalence of pregnancy-related acute renal failure in Asia: a systematic review. Saudi J. Kidney Dis. Transpl. 28, 1–8 (2017).
Google Scholar
Prakash, J. et al. Acute renal failure in pregnancy in a developing country: twenty years of experience. Ren. Fail. 28, 309–313 (2006).
Google Scholar
Berhe, E. et al. Characteristics and outcome of pregnancy-related acute kidney injury in a teaching hospital in a low-resource setting: a five-year retrospective review. BMC Nephrol. 25, 182 (2024).
Google Scholar
Shah, S. et al. Pregnancy-related acute kidney injury in the United States: clinical outcomes and health care utilization. Am. J. Nephrol. 51, 216–226 (2020).
Google Scholar
Meazaw, M. W., Chojenta, C., Muluneh, M. D. & Loxton, D. Systematic and meta-analysis of factors associated with preeclampsia and eclampsia in sub-Saharan Africa. PLoS ONE 15, e0237600 (2020).
Google Scholar
Filali Khattabi, Z. et al. Chronic kidney disease in preeclamptic patients: not found unless searched for-is a nephrology evaluation useful after an episode of preeclampsia? J. Nephrol. 32, 977–987 (2019).
Google Scholar
Ibarra-Hernandez, M. et al. Challenges in managing pregnancy in underserved women with chronic kidney disease. Am. J. Nephrol. 49, 386–396 (2019).
Google Scholar
Hall, D. R. & Conti-Ramsden, F. Acute kidney injury in pregnancy including renal disease diagnosed in pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 57, 47–59 (2019).
Google Scholar
Facca, T. A. et al. Pregnancy as an early stress test for cardiovascular and kidney disease diagnosis. Pregnancy Hypertens. 12, 169–173 (2018).
Google Scholar
Kaul, A. et al. Pregnancy check point for diagnosis of CKD in developing countries. J. Obstet. Gynaecol. India 68, 440–446 (2018).
Google Scholar
Rivera, J. C. H. et al. Delayed initiation of hemodialysis in pregnant women with chronic kidney disease: logistical problems impact clinical outcomes. an experience from an emerging country. J. Clin. Med. 8, 475 (2019).
Google Scholar
National Institute for Health Care and Excellence. Hypertension in Pregnancy: Follow-up Care and Postnatal Review (NICE, 2023).
National Institute for Health Care and Excellence. Hypertension in Pregnancy: Diagnosis and Management (NICE, 2023).
Smart, N. A., Dieberg, G., Ladhani, M. & Titus, T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst. Rev. 18, CD007333 (2014).
Huisman, R. M. The deadly risk of late referral. Nephrol. Dial. Transpl. 19, 2175–2180 (2004).
Google Scholar
Al Khalaf, S. et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, 656–670.e32 (2022).
Google Scholar
Jeyaraman, D. et al. Adverse pregnancy outcomes in pregnant women with chronic kidney disease: a systematic review and meta-analysis. BJOG 131, 1331–1340 (2024).
Google Scholar
Marek-Iannucci, S. et al. Association of chronic kidney dysfunction and preeclampsia: insights of the nationwide inpatient sample. Am. J. Obstet. Gynecol. MFM 5, 100928 (2023).
Google Scholar
Piccoli, G. B. et al. Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome. Kidney Int. 105, 865–876 (2024).
Google Scholar
Piccoli, G. B. et al. Risk of adverse pregnancy outcomes in women with CKD. J. Am. Soc. Nephrol. 26, 2011–2022 (2015).
Google Scholar
Tangren, J. S. et al. Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis. Clin. J. Am. Soc. Nephrol. 13, 612–619 (2018).
Google Scholar
Tangren, J. S. et al. Pregnancy outcomes after clinical recovery from AKI. J. Am. Soc. Nephrol. 28, 1566–1574 (2017).
Google Scholar
Tangren, J. S. et al. Risk of preeclampsia and pregnancy complications in women with a history of acute kidney injury. Hypertension 72, 451–459 (2018).
Google Scholar
Pippias, M. et al. Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance. Am. J. Transpl. 22, 2360–2380 (2022).
Google Scholar
He, Y. et al. Pregnancy in patients with stage 3–5 CKD: maternal and fetal outcomes. Pregnancy Hypertens. 29, 86–91 (2022).
Google Scholar
Wiles, K. et al. The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes. Nephrol. Dial. Transpl. 36, 2008–2017 (2021).
Google Scholar
Imbasciati, E. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney Dis. 49, 753–762 (2007).
Google Scholar
Piccoli, G. B. What is superimposed preeclampsia (and does it actually exist)? Kidney Int. Rep. 4, 759–762 (2019).
Google Scholar
Wiles, K. et al. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens. 24, 58–64 (2021).
Google Scholar
Bramham, K. et al. Predisposition to superimposed preeclampsia in women with chronic hypertension: endothelial, renal, cardiac, and placental factors in a prospective longitudinal cohort. Hypertens. Pregnancy 39, 326–335 (2020).
Google Scholar
Akbari, A. et al. Circulating angiogenic factors in a pregnant woman on intensive hemodialysis: a case report. Can. J. Kidney Health Dis. 3, 7 (2016).
Google Scholar
Shanmugalingam, R., Cole-Clark, A., Lowrie, E., Hennessy, A. & Makris, A. Clinical use of angiogenic factors in managing a pregnant woman on hemodialysis to term. Kidney Int. Rep. 6, 1449–1453 (2021).
Google Scholar
Morisawa, H. et al. Difficulty of predicting early-onset super-imposed preeclampsia in pregnant women with hemodialysis due to diabetic nephropathy by serum levels of sFlt-1, PlGF, and sEng. CEN Case Rep. 9, 101–105 (2020).
Google Scholar
Gosselink, M. E. et al. A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int. 102, 866–875 (2022).
Google Scholar
Hewawasam, E. et al. Determinants of perinatal outcomes in dialyzed and transplanted women in Australia. Kidney Int. Rep. 7, 1318–1331 (2022).
Google Scholar
Shah, S. et al. Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol. 20, 24 (2019).
Google Scholar
Lu, J. et al. Preeclampsia after kidney transplantation: rates and association with graft survival and function. Clin. J. Am. Soc. Nephrol. 18, 920–929 (2023).
Google Scholar
Dines, V., D’Costa, M., Fidler, M. & Kattah, A. The role of kidney biopsy in diagnosis of preeclampsia in kidney transplant patients. Hypertens. Pregnancy 39, 418–422 (2020).
Google Scholar
Majak, G. B. et al. Preeclampsia in kidney transplanted women; outcomes and a simple prognostic risk score system. PLoS ONE 12, e0173420 (2017).
Google Scholar
Vannevel, V. et al. Preeclampsia and long-term renal function in women who underwent kidney transplantation. Obstet. Gynecol. 131, 57–62 (2018).
Google Scholar
Park, S. et al. Pregnancy in women with immunoglobulin A nephropathy: are obstetrical complications associated with renal prognosis? Nephrol. Dial. Transpl. 33, 459–465 (2018).
Google Scholar
Luyckx, V. A. & Brenner, B. M. Clinical consequences of developmental programming of low nephron number. Anat. Rec. 303, 2613–2631 (2020).
Google Scholar
Li, F. et al. Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: a meta-analysis of cohort studies. Pregnancy Hypertens. 24, 107–117 (2021).
Google Scholar
Wu, C. S. et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am. J. Obstet. Gynecol. 201, 269.e1–269.e10 (2009).
Google Scholar
Koulouraki, S. et al. Short- and long-term outcomes of preeclampsia in offspring: review of the literature. Children 10, 826 (2023).
Google Scholar
Turbeville, H. R. & Sasser, J. M. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am. J. Physiol. Renal Physiol. 318, F1315–F1326 (2020).
Google Scholar
Ratsep, M. T. et al. Impact of preeclampsia on cognitive function in the offspring. Behav. Brain Res. 302, 175–181 (2016).
Google Scholar
Kokori, E. et al. Maternal and fetal neurocognitive outcomes in preeclampsia and eclampsia; a narrative review of current evidence. Eur. J. Med. Res. 29, 470 (2024).
Google Scholar
Bokslag, A., van Weissenbruch, M., Mol, B. W. & de Groot, C. J. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum. Dev. 102, 47–50 (2016).
Google Scholar
Chappell, L. C. et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet 394, 1181–1190 (2019).
Google Scholar
Wang, Y. et al. Aspirin for the prevention of preeclampsia: a systematic review and meta-analysis of randomized controlled studies. Front. Cardiovasc. Med. 9, 936560 (2022).
Google Scholar
Roberge, S. et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 216, 110–120 e116 (2017).
Google Scholar
North, R. A., Ferrier, C., Gamble, G., Fairley, K. F. & Kincaid-Smith, P. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust. N. Z. J. Obstet. Gynaecol. 35, 357–362 (1995).
Google Scholar
de Vries, J. I. et al. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J. Thromb. Haemost. 10, 64–72 (2012).
Google Scholar
van Hoorn, M. E. et al. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. Eur. J. Obstet. Gynecol. Reprod. Biol. 197, 168–173 (2016).
Google Scholar
Martinelli, I. et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 119, 3269–3275 (2012).
Google Scholar
Haddad, B. et al. Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial. Obstet. Gynecol. 128, 1053–1063 (2016).
Google Scholar
Wang, X. & Gao, H. Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis. J. Matern. Fetal Neonatal Med. 33, 2202–2208 (2020).
Google Scholar
McLaughlin, K., Scholten, R. R., Parker, J. D., Ferrazzi, E. & Kingdom, J. C. P. Low molecular weight heparin for the prevention of severe preeclampsia: where next? Br. J. Clin. Pharmacol. 84, 673–678 (2018).
Google Scholar
Cruz-Lemini, M., Vazquez, J. C., Ullmo, J. & Llurba, E. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, S1126–S1144.e17 (2022).
Google Scholar
Dwarkanath, P. et al. Two randomized trials of low-dose calcium supplementation in pregnancy. N. Engl. J. Med. 390, 143–153 (2024).
Google Scholar
Woo Kinshella, M. L. et al. Calcium for pre-eclampsia prevention: a systematic review and network meta-analysis to guide personalised antenatal care. BJOG 129, 1833–1843 (2022).
Google Scholar
Evenepoel, P. et al. Recommended calcium intake in adults and children with chronic kidney disease — a European consensus statement. Nephrol. Dial. Transpl. 39, 341–366 (2024).
Google Scholar
Aguilar, A. et al. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis. Front. Physiol. 14, 1177829 (2023).
Google Scholar
World Health Organisation. WHO Recommendation: Calcium Supplementation during Pregnancy for the Prevention of Pre-eclampsia and its Complications (WHO, 2018).
Hofmeyr, G. J., Lawrie, T. A., Atallah, A. N. & Torloni, M. R. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. 10, CD001059 (2018).
Google Scholar
Bhowmik, B. et al. Maternal BMI and nutritional status in early pregnancy and its impact on neonatal outcomes at birth in Bangladesh. BMC Pregnancy Childbirth 19, 413 (2019).
Google Scholar
World Health organization. WHO Antenatal Care Recommendations for a Positive Pregnancy Experience — Nutritional Interventions Update: Vitamin D Supplements during Pregnancy (WHO, 2020).
Palacios, C., Kostiuk, L. L., Cuthbert, A. & Weeks, J. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst. Rev. 7, CD008873 (2024).
Google Scholar
Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011).
Google Scholar
Vadillo-Ortega, F. et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 342, d2901 (2011).
Google Scholar
Taliento, C. et al. Effect of physical activity during pregnancy on the risk of hypertension disorders and gestational diabetes: evidence generated by new RCTs and systematic reviews. J. Clin. Med. 13, 2198 (2024).
Google Scholar
European Commission. Dietary recommendations for protein intake for pregnant and lactating women. EC (2021).
Ikizler, T. A. et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am. J. Kidney Dis. 76, S1–S107 (2020).
Google Scholar
Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids (National Academies, 2005).
Perry, A., Stephanou, A. & Rayman, M. P. Dietary factors that affect the risk of pre-eclampsia. BMJ Nutr. Prev. Health 5, 118–133 (2022).
Google Scholar
Raghavan, R. et al. Dietary patterns before and during pregnancy and birth outcomes: a systematic review. Am. J. Clin. Nutr. 109, 729S–756S (2019).
Google Scholar
Brantsaeter, A. L. et al. A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J. Nutr. 139, 1162–1168 (2009).
Google Scholar
Hall, K. D. et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 30, 226 (2019).
Google Scholar
Attini, R. et al. Plant-based diets improve maternal-fetal outcomes in CKD pregnancies. Nutrients 14, 4203 (2022).
Google Scholar
Piccoli, G. B. et al. Vegetarian supplemented low-protein diets. A safe option for pregnant CKD patients: report of 12 pregnancies in 11 patients. Nephrol. Dial. Transpl. 26, 196–205 (2011).
Google Scholar
Piccoli, G. B. et al. Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin. J. Am. Soc. Nephrol. 9, 864–873 (2014).
Google Scholar
Vilar-Compte, M. et al. Urban poverty and nutrition challenges associated with accessibility to a healthy diet: a global systematic literature review. Int. J. Equity Health 20, 40 (2021).
Google Scholar
Syngelaki, A. et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434–443 (2016).
Google Scholar
Alqudah, A. et al. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabet. Med. 35, 160–172 (2018).
Google Scholar
Costantine, M. M. et al. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am. J. Obstet. Gynecol. 214, 720.e1–720.e17 (2016).
Google Scholar
Costantine, M. M. et al. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia. Am. J. Obstet. Gynecol. 225, 666.e1–666.e15 (2021).
Google Scholar
Akbar, M. I. A. et al. INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high-risk patients. Am. J. Perinatol. 41, 1203–1211 (2024).
Google Scholar
Ahmed, A. et al. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial. BJOG 127, 478–488 (2020).
Google Scholar
Rozas-Villanueva, M. F., Casanello, P. & Retamal, M. A. Role of ROS/RNS in preeclampsia: are connexins the missing piece? Int. J. Mol. Sci. 21, 4698 (2020).
Google Scholar
Brownfoot, F. C. et al. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. BMC Pregnancy Childbirth 16, 117 (2016).
Google Scholar
Meijerink, L. et al. Statins in pre-eclampsia or fetal growth restriction: a systematic review and meta-analysis on maternal blood pressure and fetal growth across species. BJOG 130, 577–585 (2023).
Google Scholar
Kattah, A. et al. Complement C5 inhibition as a novel therapeutic approach in severe pre-eclampsia. Mayo Clin. Proc. 97, 1580–1583 (2022).
Google Scholar
Thadhani, R. et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940–950 (2011).
Google Scholar
Gilbert, J. S. et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placental ischemia-induced hypertension. Hypertension 55, 380–385 (2010).
Google Scholar
Hamano, T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat. Clin. Pract. Nephrol. 5, 8–9 (2009).
Google Scholar
Piccoli, G. B. et al. The ABCs of post-preeclampsia outpatient nephrology care: the Le Mans strategy. J. Nephrol. 37, 2481–2489 (2024).
Google Scholar
Inversetti, A. et al. Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. Eur. Heart J. Qual. Care Clin. Outcomes 10, 4–13 (2024).
Google Scholar
Staff, A. C., Costa, M. L., Dechend, R., Jacobsen, D. P. & Sugulle, M. Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: bridging epidemiological knowledge into personalized postpartum care and follow-up. Pregnancy Hypertens. 36, 101127 (2024).
Google Scholar
Daubert, M. A. et al. Early postpartum blood pressure screening is associated with increased detection of cardiovascular risk factors in women with hypertensive disorders of pregnancy. Am. Heart J. 273, 130–139 (2024).
Google Scholar
Ackerman-Banks, C. M. et al. Seizing the window of opportunity within 1 year postpartum: early cardiovascular screening. J. Am. Heart Assoc. 11, e024443 (2022).
Google Scholar
Conti-Ramsden, F., Bramham, K. & de Marvao, A. Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action. Eur. Heart J. Qual. Care Clin. Outcomes 10, 1–3 (2024).
Google Scholar
Wu, P. et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes 10, e003497 (2017).
Google Scholar
Lo, C. C. W. et al. Future cardiovascular disease risk for women with gestational hypertension: a systematic review and meta-analysis. J. Am. Heart Assoc. 9, e013991 (2020).
Google Scholar
Tannor, E. K., Nlandu, Y. M., Elrggal, M. E., Chika, O. U. & Nzana, V. Kidney health for all — bridging the gap to better kidney care in Africa. Afr. J. Nephrol. 25, 108–115 (2022).
Talle, M. A. et al. Status of cardiac arrhythmia services in Africa in 2018: a PASCAR sudden cardiac death task force report. Cardiovasc. J. Afr. 29, 115–121 (2018).
Google Scholar
Gonçalves, M. A. A., Morais, H., Oliveira, G. M. M. D. & Mesquita, C. T. Challenges and perspectives for cardiology in the developing world: joint views from Africa and Latin America. Int. J. Cardiovasc. Sci. 37, e20240002 (2024).
Anumudu, S. J. & Fadem, S. Z. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 173–186 (Springer, 2021).
Bellasi, A. et al. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 557–568 (Springer, 2021).
European Society of Cardiology. Cardiologists (total) (per million people). ESC (2024).
Canaud, B. & Choukroun, G. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 521–541 (Springer, 2021).
European Society of Cardiology. French Society of Cardiology. ESC (2024).
Schulz, C. et al. Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines. J. Nephrol. 35, 1375–1385 (2022).
Google Scholar
Jesudason, S. Implementing referral systems for nephrology services: real world practice versus guidelines. J. Nephrol. 35, 1369–1370 (2022).
Google Scholar
Li, K. et al. Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care. Intern. Med. J. 54, 1126–1135 (2024).
Google Scholar
Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473–485 (2024).
Google Scholar
Carrero, J. J., Hecking, M., Chesnaye, N. C. & Jager, K. J. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat. Rev. Nephrol. 14, 151–164 (2018).
Google Scholar
Li, L. et al. Trophoblast-targeted nanomedicine modulates placental sFLT1 for preeclampsia treatment. Front. Bioeng. Biotechnol. 8, 64 (2020).
Google Scholar
Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nat. Biotechnol. 36, 1164–1173 (2018).
Google Scholar
PRNewswire. Comanche Biopharma receives US FDA fast track designation for CBP-4888 for the treatment of sFlt-1 mediated pre-term preeclampsia. PRNewswire (2023).
Wang, Y. et al. Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus. Apher. Sci. 35, 103–110 (2006).
Google Scholar
Winkler, K. et al. Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: the Freiburg preeclampsia H.E.L.P.-apheresis study. Pregnancy Hypertens. 12, 136–143 (2018).
Google Scholar
Nakakita, B. et al. Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks’ gestation. J. Obstet. Gynaecol. Res. 41, 1661–1663 (2015).
Google Scholar
Gubensek, J. et al. Treatment of preeclampsia at extremely preterm gestation with therapeutic plasma exchange. Clin. Nephrol. 96, 101–106 (2021).
Google Scholar
Thadhani, R. et al. Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J. Am. Soc. Nephrol. 27, 903–913 (2016).
Google Scholar
Haddad, B. et al. LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: report of two cases from a discontinued phase II trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 231, 70–74 (2018).
Google Scholar
Logue, O. C., Mahdi, F., Chapman, H., George, E. M. & Bidwell, G. L. 3rd A maternally sequestered, biopolymer-stabilized vascular endothelial growth factor (VEGF) chimera for treatment of preeclampsia. J. Am. Heart Assoc. 6, e007216 (2017).
Google Scholar
Waller, J. P., Howell, J. A., Peterson, H., George, E. M. & Bidwell, G. L. 3rd Elastin-like polypeptide: VEGF-B fusion protein for treatment of preeclampsia. Hypertension 78, 1888–1901 (2021).
Google Scholar
Engel, J. E. et al. Recovery of renal function following kidney-specific VEGF therapy in experimental renovascular disease. Am. J. Nephrol. 51, 891–902 (2020).
Google Scholar
Kadife, E. et al. Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro. PLoS ONE 17, e0271560 (2022).
Google Scholar
de Moreuil, C., Alavi, Z. & Pasquier, E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. Br. J. Clin. Pharmacol. 86, 39–49 (2020).
Google Scholar
Pierik, E. et al. Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia? Front. Immunol. 10, 3098 (2019).
Google Scholar
Morales, E. et al. Eculizumab in early-stage pregnancy. Kidney Int. Rep. 5, 2383–2387 (2020).
Google Scholar
Neri, I., Jasonni, V. M., Gori, G. F., Blasi, I. & Facchinetti, F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J. Matern. Fetal Neonatal Med. 19, 277–281 (2006).
Google Scholar
Winer, N. et al. Oral citrulline supplementation in pregnancies with preeclampsia: a multicenter, randomized, double-blind clinical trial. Am. J. Clin. Nutr. 121, 488–496 (2025).
Google Scholar
Saleh, L. et al. Low soluble Fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors. Hypertension 70, 594–600 (2017).
Google Scholar
Cluver, C. A. et al. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. Am. J. Obstet. Gynecol. 219, 388.e1–388.e17 (2018).
Google Scholar
Kobayashi, T. et al. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Semin. Thromb. Hemost. 29, 645–652 (2003).
Google Scholar
Maki, M. et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 study group. Thromb. Haemost. 84, 583–590 (2000).
Google Scholar
Paidas, M. J. et al. Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia. Am. J. Obstet. Gynecol. 223, 739.e1–739.e13 (2020).
Google Scholar
Chen, J., Huai, J. & Yang, H. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis. BMC Pregnancy Childbirth 24, 68 (2024).
Google Scholar
Socha, M. W., Chmielewski, J., Pietrus, M. & Wartega, M. Endogenous digitalis-like factors as a key molecule in the pathophysiology of pregnancy-induced hypertension and a potential therapeutic target in preeclampsia. Int. J. Mol. Sci. 24, 12743 (2023).
Google Scholar
GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global burden of disease study 2021. Lancet 403, 2057–2099 (2024).
Google Scholar
Brouwers, L. et al. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG 125, 1642–1654 (2018).
Google Scholar
link